Projected costs of ischemic stroke in the United States

被引:174
作者
Brown, D. L.
Boden-Albala, B.
Langa, K. M.
Lisabeth, L. D.
Fair, M.
Smith, M. A.
Sacco, R. L.
Morgenstern, L. B.
机构
[1] Univ Michigan, Sch Med, Stroke Program, Ann Arbor, MI 48109 USA
[2] Univ Michigan, Sch Med, Div Gen Med, Ann Arbor, MI 48109 USA
[3] Univ Michigan, Sch Med, Dept Internal Med, Ann Arbor, MI 48109 USA
[4] Univ Michigan, Vet Affairs Ctr Practice Management & Outcomes Re, Inst Social Res, Ann Arbor, MI 48109 USA
[5] Univ Michigan, Sch Publ Hlth, Dept Epidemiol, Ann Arbor, MI 48109 USA
[6] Columbia Univ, Coll Phys & Surg, Dept Neurol, New York, NY 10027 USA
[7] Columbia Univ, Mailman Sch Publ Hlth, Dept Sociomed Sci, New York, NY USA
[8] Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY USA
关键词
D O I
10.1212/01.wnl.0000237024.16438.20
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: There are barriers to acute stroke care in minority groups as well as a higher incidence of ischemic stroke when compared with non-Hispanic whites. Objective: To estimate the future economic burden of stroke in non-Hispanic whites, Hispanics, and African Americans in the United States from 2005 to 2050. Methods: We used U.S. Census estimates of the race-ethnic group populations age 45 years and older. We obtained stroke epidemiology and service utilization data from the Northern Manhattan Stroke Study and the Brain Attack Surveillance in Corpus Christi project and other published data. We estimated costs directly from Medicare reimbursement or from studies that used Medicare reimbursement. Direct and indirect costs considered included ambulance services, initial hospitalization, rehabilitation, nursing home costs, outpatient clinic visits, drugs, informal caregiving, and potential lost earnings. Results: The total cost of stroke from 2005 to 2050, in 2005 dollars, is projected to be $1.52 trillion for non-Hispanic whites, $313 billion for Hispanics, and $379 billion for African Americans. The per capita cost of stroke estimates are highest in African Americans ($25,782), followed by Hispanics ($17,201), and non-Hispanic whites ($15,597). Loss of earnings is expected to be the highest cost contributor in each race-ethnic group. Conclusions: The economic burden of stroke in African Americans and Hispanics will be enormous over the next several decades. Further efforts to improve stroke prevention and treatment in these high stroke risk groups are necessary.
引用
收藏
页码:1390 / 1395
页数:6
相关论文
共 36 条
[1]   Improving efficiency of stroke research:: The Brain Attack Surveillance in Corpus Christi Study [J].
Al-Wabil, A ;
Smith, MA ;
Moyé, LA ;
Burgin, WS ;
Morgenstern, LB .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 2003, 56 (04) :351-357
[2]  
*AM HEART ASS, 2004, HEART DIS STROK
[3]  
*BUR CENS, 1995, P25 1130 POP PROJ US
[4]   Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure [J].
Chobanian, AV ;
Bakris, GL ;
Black, HR ;
Cushman, WC ;
Green, LA ;
Izzo, JL ;
Jones, DW ;
Materson, BJ ;
Oparil, S ;
Wright, JT ;
Roccella, EJ .
HYPERTENSION, 2003, 42 (06) :1206-1252
[5]   Racial disparities in receipt of secondary stroke prevention agents among US nursing home residents [J].
Christian, JB ;
Lapane, KL ;
Toppa, RS .
STROKE, 2003, 34 (11) :2693-2697
[6]   Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) [J].
Cleeman, JI ;
Grundy, SM ;
Becker, D ;
Clark, LT ;
Cooper, RS ;
Denke, MA ;
Howard, WJ ;
Hunninghake, DB ;
Illingworth, DR ;
Luepker, RV ;
McBride, P ;
McKenney, JM ;
Pasternak, RC ;
Stone, NJ ;
Van Horn, L ;
Brewer, HB ;
Ernst, ND ;
Gordon, D ;
Levy, D ;
Rifkind, B ;
Rossouw, JE ;
Savage, P ;
Haffner, SM ;
Orloff, DG ;
Proschan, MA ;
Schwartz, JS ;
Sempos, CT ;
Shero, ST ;
Murray, EZ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (19) :2486-2497
[7]   Issues of race, ethnicity, and culture in caregiving research: A 20-year review (1980-2000) [J].
Dilworth-Anderson, P ;
Williams, IC ;
Gibson, BE .
GERONTOLOGIST, 2002, 42 (02) :237-272
[8]  
Elliott William J, 2003, J Clin Hypertens (Greenwich), V5, P3, DOI 10.1111/j.1524-6175.2003.02463.x
[9]   Cost-effectiveness of tissue plasminogen activator for acute ischemic stroke [J].
Fagan, SC ;
Morgenstern, LB ;
Petitta, A ;
Ward, RE ;
Tilley, BC ;
Marler, JR ;
Levine, SR ;
Broderick, JP ;
Kwiatkowski, TG ;
Frankel, M ;
Brott, TG ;
Walker, MD .
NEUROLOGY, 1998, 50 (04) :883-890
[10]   Cost-effectiveness of preference-based antithrombotic therapy for patients with nonvalvular atrial fibrillation [J].
Gage, BF ;
Cardinalli, AB ;
Owens, DK .
STROKE, 1998, 29 (06) :1083-1091